In line with the Egyptian Drug Authority's (EDA) commitment to promoting the safe and rational use of medicines and enhancing patient safety, the Authority announces the release of the Egyptian Do Not Crush Medication List 2026. This initiative is part of its ongoing efforts to provide a reliable scientific reference that supports healthcare providers and patients, elevating the standards of safe, evidence-based pharmaceutical practice.

The list provides a clear classification of pharmacological groups and specific products that must not be crushed, broken, or chewed. This primarily includes extended-release and enteric-coated dosage forms. The document also outlines the clinical risks and potential adverse effects of mishandling these preparations, which can directly impact treatment efficacy and patient safety.

The EDA emphasizes that issuing this list supports rational pharmacy practices and aims to reduce medication errors and improve the quality of healthcare. This is particularly crucial for patients requiring medication via feeding tubes or those suffering from swallowing difficulties (dysphagia). The Authority calls upon all pharmacists and healthcare providers to consult and follow this list in their professional practice to ensure the highest standards of medication safety.